Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsila Zuckerman

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|December 15, 2018
Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cellsShlomit Yehudai-Resheff, Shira Attias-Turgeman, Rawan Sabbah, et al.
Annals of Hematology|June 13, 2019
Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective studyRon Ram, Odelia Amit, Tsila Zuckerman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trialDror Mevorach, Tsila Zuckerman, Inna Reiner, et al.
British Journal of Haematology|December 16, 2014
Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patientsLior Carmon, Irit Avivi, Riva Kovjazin, et al.
Transplantation and Cellular Therapy|December 26, 2021
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome StructureHaneen Daoud-Asfour, Israel Henig, Itai Ghersin, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2015
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort studyNizar Andria, Oryan Henig, Offer Kotler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 20, 2014
Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation-can preemptive detection of John Cunningham virus be useful?Irit Avivi, Talya Wittmann, Israel Henig, et al.
Therapeutic Drug Monitoring|November 5, 2021
Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With PhenytoinTareq Artul, Israel Henig, Laila Nassar, et al.
Haematologica|February 5, 2026
FLAG-IDA-Venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world studyBaher Krayem, Avraham Frisch, Dana Yehudai-Ofir, et al.
Harefuah|April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|December 15, 2018
Abnormal morphological and functional nature of bone marrow stromal cells provides preferential support for survival of acute myeloid leukemia cellsShlomit Yehudai-Resheff, Shira Attias-Turgeman, Rawan Sabbah, et al.
Annals of Hematology|June 13, 2019
Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective studyRon Ram, Odelia Amit, Tsila Zuckerman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trialDror Mevorach, Tsila Zuckerman, Inna Reiner, et al.
British Journal of Haematology|December 16, 2014
Phase I/II study exploring ImMucin, a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patientsLior Carmon, Irit Avivi, Riva Kovjazin, et al.
Transplantation and Cellular Therapy|December 26, 2021
Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome StructureHaneen Daoud-Asfour, Israel Henig, Itai Ghersin, et al.
The Journal of Antimicrobial Chemotherapy|July 26, 2015
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort studyNizar Andria, Oryan Henig, Offer Kotler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 20, 2014
Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation-can preemptive detection of John Cunningham virus be useful?Irit Avivi, Talya Wittmann, Israel Henig, et al.
Therapeutic Drug Monitoring|November 5, 2021
Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With PhenytoinTareq Artul, Israel Henig, Laila Nassar, et al.
Haematologica|February 5, 2026
FLAG-IDA-Venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world studyBaher Krayem, Avraham Frisch, Dana Yehudai-Ofir, et al.
Harefuah|April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.
Pageof 11